MedTrace Logo

Fluid Volume During Fluid Shifts

NCT03447574 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2022-12-08

No results posted yet for this study

Summary

This study is designed to answer the question of if several non-invasive methods are comparable to the invasive clinical gold standard of radiolabeled albumin in terms of detecting changes in fluid volume.

It is broken into two studies: Aim 1 Study A is designed as a pilot phase to develop the non-techniques, and Aim 2 Study B is comparing these techniques to the gold standard.

Conditions

  • Development of Non-invasive Protocol

Interventions

OTHER

ethanol dilution

Ethanol has been validated against deuterium oxide, the invasive gold standard for determining totally body water

Sponsors & Collaborators

Principal Investigators

  • Bruce D Johnson · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-27
Primary Completion
2022-10-26
Completion
2022-10-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03447574 on ClinicalTrials.gov